Emergent BioSolutions (EBS) stock forecast for 2025. Forecast tables and graphs.

Emergent BioSolutions (EBS) stock forecast for 2025

Last update: 08-15-2022, 9:58

Sector: Healthcare

The share price of Emergent BioSolutions Inc. (EBS) now

What analysts predict:: $41.21

52-week high/low: $65.09 / $26.85

50/200 Day Moving Average: $31.45 / $38.89

This figure corresponds to the average price over the previous 50/200 days. For Emergent BioSolutions stocks, the 50-day moving average is the support level today.

For Emergent BioSolutions stocks, the 200-day moving average is the resistance level today.

Are you interested in Emergent BioSolutions stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Emergent BioSolutions stock price in 2025. How much will one Emergent BioSolutions share be worth in 2025?

Is it worth taking profit / loss on Emergent BioSolutions stock now or waiting? What are analysts' forecasts for Emergent BioSolutions stock?

We forecast Emergent BioSolutions stock performance using neural networks based on historical data on Emergent BioSolutions stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.

The Emergent BioSolutions stock prediction results are shown below and presented as a graph, table and text information.

Emergent BioSolutions stock forecasts are adjusted once a day based on the closing price of the previous trading day.

The minimum target price for Emergent BioSolutions analysts is $41.21.

Today 200 Day Moving Average is the resistance level (38.89 $).

50 Day Moving Average is the support level (31.45 $).




Historical and forecast chart of Emergent BioSolutions stock

The chart below shows the historical price of Emergent BioSolutions stock and a prediction chart for the next year. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the Emergent BioSolutions stock price can be found in the table below.

Emergent BioSolutions (EBS) Forecast for 2025

Month Target Pes. Opt. Vol., %
Jan 38.34 36.56 39.05 6.39 %
Feb 37.23 34.95 38.51 9.26 %
Mar 34.77 33.58 36.42 7.81 %
Apr 35.19 33.23 37.22 10.73 %
May 34.87 32.50 36.65 11.32 %
Jun 37.69 36.95 38.60 4.27 %
Jul 39.58 37.19 41.09 9.50 %
Aug 41.57 39.13 44.20 11.46 %
Sep 43.50 40.63 44.51 8.73 %
Oct 44.84 42.21 48.09 12.23 %
Nov 48.09 45.27 50.86 10.99 %
Dec 48.85 46.94 50.53 7.10 %

Emergent BioSolutions information and performance

Emergent BioSutions Inc. is a global biopharmaceutical company that develops, manufactures and provides a portfolio of medical countermeasures for biological and chemical threats, as well as emerging infectious diseases for hospitals and clinics.

Official site of the company

Emergent BioSolutions Address

400 PROFESSIONAL DR, SUITE 400, GAITHERSBURG, MD, US

Market Capitalization: 1 520 776 000 $

Market capitalization is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of shares in the company outstanding by the market price of one share.

EBITDA: 340 700 000 $

EBITDA is earnings before interest, income tax and depreciation of assets.

PE Ratio: 17.53

P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit

PEG Ratio: 1.55

Price/earnings to growth

DPS: N/A

Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.

DY: N/A

Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.

EPS: 1.74

EPS shows how much of the net profit is accounted for by the common share.

Quarterly Earnings Growth YOY: 0.022

Quarterly Revenue Growth YOY: -0.389

Trailing PE: 17.53

Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.

Forward PE: 24.39

Forward P/E uses projections of future earnings instead of final numbers.

EV To Revenue: 1.241

Enterprise Value (EV) /Revenue

EV To EBITDA: 6.49

The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).

Shares Outstanding: 49861500

Number of issued ordinary shares

Shares Float: N/A

Number of freely tradable shares

Shares Short Prior Month: N/A

Shares Short Prior Month - the number of shares in short positions in the last month.

Short Ratio: N/A

Percent Insiders: N/A

Percent Institutions: N/A

Emergent BioSolutions price target for 2021 by month


Target values for the price of one Emergent BioSolutions share for Jan 2025.

The weighted average target price per Emergent BioSolutions share in Jan 2025 is: 38.34. In Jan, the negative dynamics for Momo shares will prevail with possible monthly volatility of 6.391% volatility is expected.

Pessimistic target level: 36.56

Optimistic target level: 39.05


Target values for the price of one Emergent BioSolutions share for Feb 2025.

The weighted average target price per Emergent BioSolutions share in Feb 2025 is: 37.23. In Feb, the negative dynamics for Momo shares will prevail with possible monthly volatility of 9.260% volatility is expected.

Pessimistic target level: 34.95

Optimistic target level: 38.51


Target values for the price of one Emergent BioSolutions share for Mar 2025.

The weighted average target price per Emergent BioSolutions share in Mar 2025 is: 34.77. In Mar, the negative dynamics for Momo shares will prevail with possible monthly volatility of 7.813% volatility is expected.

Pessimistic target level: 33.58

Optimistic target level: 36.42


Target values for the price of one Emergent BioSolutions share for Apr 2025.

The weighted average target price per Emergent BioSolutions share in Apr 2025 is: 35.19. In Apr, the positive dynamics for Momo shares will prevail with possible monthly volatility of 10.727% volatility is expected.

Pessimistic target level: 33.23

Optimistic target level: 37.22


Target values for the price of one Emergent BioSolutions share for May 2025.

The weighted average target price per Emergent BioSolutions share in May 2025 is: 34.87. In May, the negative dynamics for Momo shares will prevail with possible monthly volatility of 11.325% volatility is expected.

Pessimistic target level: 32.50

Optimistic target level: 36.65


Target values for the price of one Emergent BioSolutions share for Jun 2025.

The weighted average target price per Emergent BioSolutions share in Jun 2025 is: 37.69. In Jun, the positive dynamics for Momo shares will prevail with possible monthly volatility of 4.268% volatility is expected.

Pessimistic target level: 36.95

Optimistic target level: 38.60


Target values for the price of one Emergent BioSolutions share for Jul 2025.

The weighted average target price per Emergent BioSolutions share in Jul 2025 is: 39.58. In Jul, the positive dynamics for Momo shares will prevail with possible monthly volatility of 9.496% volatility is expected.

Pessimistic target level: 37.19

Optimistic target level: 41.09


Target values for the price of one Emergent BioSolutions share for Aug 2025.

The weighted average target price per Emergent BioSolutions share in Aug 2025 is: 41.57. In Aug, the positive dynamics for Momo shares will prevail with possible monthly volatility of 11.458% volatility is expected.

Pessimistic target level: 39.13

Optimistic target level: 44.20


Target values for the price of one Emergent BioSolutions share for Sep 2025.

The weighted average target price per Emergent BioSolutions share in Sep 2025 is: 43.50. In Sep, the positive dynamics for Momo shares will prevail with possible monthly volatility of 8.725% volatility is expected.

Pessimistic target level: 40.63

Optimistic target level: 44.51


Target values for the price of one Emergent BioSolutions share for Oct 2025.

The weighted average target price per Emergent BioSolutions share in Oct 2025 is: 44.84. In Oct, the positive dynamics for Momo shares will prevail with possible monthly volatility of 12.226% volatility is expected.

Pessimistic target level: 42.21

Optimistic target level: 48.09


Target values for the price of one Emergent BioSolutions share for Nov 2025.

The weighted average target price per Emergent BioSolutions share in Nov 2025 is: 48.09. In Nov, the positive dynamics for Momo shares will prevail with possible monthly volatility of 10.991% volatility is expected.

Pessimistic target level: 45.27

Optimistic target level: 50.86


Target values for the price of one Emergent BioSolutions share for Dec 2025.

The weighted average target price per Emergent BioSolutions share in Dec 2025 is: 48.85. In Dec, the positive dynamics for Momo shares will prevail with possible monthly volatility of 7.103% volatility is expected.

Pessimistic target level: 46.94

Optimistic target level: 50.53




Related stocks from Healthcare sector


Disclaimer:

All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and, moreover, are not trading signals. When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market as a result of using the information contained on the site.